165 related articles for article (PubMed ID: 23526138)
1. Evaluation of bone remodeling with (18)F-fluoride and correlation with the glucose metabolism measured by (18)F-FDG in lumbar spine with time in an experimental nude rat model with osteoporosis using dynamic PET-CT.
Cheng C; Heiss C; Dimitrakopoulou-Strauss A; Govindarajan P; Schlewitz G; Pan L; Schnettler R; Weber K; Strauss LG
Am J Nucl Med Mol Imaging; 2013; 3(2):118-28. PubMed ID: 23526138
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of new bone formation in normal and osteoporotic rats with a 3-mm femur defect: functional assessment with dynamic PET-CT (dPET-CT) using 2-deoxy-2-[(18)F]fluoro-D-glucose ( (18)F-FDG) and (18)F-fluoride.
Cheng C; Alt V; Dimitrakopoulou-Strauss A; Pan L; Thormann U; Schnettler R; Weber K; Strauss LG
Mol Imaging Biol; 2013 Jun; 15(3):336-44. PubMed ID: 22965489
[TBL] [Abstract][Full Text] [Related]
3. PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.
Sachpekidis C; Goldschmidt H; Hose D; Pan L; Cheng C; Kopka K; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1343-53. PubMed ID: 24562650
[TBL] [Abstract][Full Text] [Related]
4. Application of F-18-sodium fluoride (NaF) dynamic PET-CT (dPET-CT) for defect healing: a comparison of biomaterials in an experimental osteoporotic rat model.
Cheng C; Alt V; Pan L; Thormann U; Schnettler R; Strauss LG; Heinemann S; Schumacher M; Gelinsky M; Nies B; Dimitrakopoulou-Strauss A
Med Sci Monit; 2014 Oct; 20():1942-9. PubMed ID: 25317537
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evaluation of different biomaterials for defect healing in an experimental osteoporotic rat model with dynamic PET-CT (dPET-CT) using F-18-sodium fluoride (NaF).
Cheng C; Alt V; Pan L; Thormann U; Schnettler R; Strauss LG; Schumacher M; Gelinsky M; Dimitrakopoulou-Strauss A
Injury; 2014 Mar; 45(3):501-5. PubMed ID: 24332163
[TBL] [Abstract][Full Text] [Related]
6. Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.
Sachpekidis C; Thieke C; Askoxylakis V; Nicolay NH; Huber PE; Thomas M; Dimitrakopoulou G; Debus J; Haberkorn U; Dimitrakopoulou-Strauss A
Am J Nucl Med Mol Imaging; 2015; 5(2):127-42. PubMed ID: 25973334
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
Koukouraki S; Strauss LG; Georgoulias V; Eisenhut M; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1115-22. PubMed ID: 16763820
[TBL] [Abstract][Full Text] [Related]
8. Treatment response evaluation with
Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
[TBL] [Abstract][Full Text] [Related]
9. Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: relation to differential diagnosis, tumor grading and prediction of prognosis.
Okazumi S; Dimitrakopoulou-Strauss A; Schwarzbach MH; Strauss LG
Hell J Nucl Med; 2009; 12(3):223-8. PubMed ID: 19936332
[TBL] [Abstract][Full Text] [Related]
10. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H
J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
Frost ML; Fogelman I; Blake GM; Marsden PK; Cook G
J Bone Miner Res; 2004 Nov; 19(11):1797-804. PubMed ID: 15476579
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a short dynamic 18F-fluoride PET/CT scanning method to assess bone metabolic activity in spinal orthopedics.
Peters MJ; Wierts R; Jutten EM; Halders SG; Willems PC; Brans B
Ann Nucl Med; 2015 Nov; 29(9):799-809. PubMed ID: 26243500
[TBL] [Abstract][Full Text] [Related]
13. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
14. The influence of CT and dual-energy X-ray absorptiometry (DXA) bone density on quantitative [
Jassel IS; Siddique M; Frost ML; Moore AEB; Puri T; Blake GM
Quant Imaging Med Surg; 2019 Feb; 9(2):201-209. PubMed ID: 30976544
[TBL] [Abstract][Full Text] [Related]
15. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions.
Dimitrakopoulou-Strauss A; Strauss LG; Heichel T; Wu H; Burger C; Bernd L; Ewerbeck V
J Nucl Med; 2002 Apr; 43(4):510-8. PubMed ID: 11937595
[TBL] [Abstract][Full Text] [Related]
16. Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy.
Dimitrakopoulou-Strauss A; Strauss LG; Burger C; Rühl A; Irngartinger G; Stremmel W; Rudi J
J Nucl Med; 2004 Sep; 45(9):1480-7. PubMed ID: 15347714
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.
Frost ML; Cook GJ; Blake GM; Marsden PK; Benatar NA; Fogelman I
J Bone Miner Res; 2003 Dec; 18(12):2215-22. PubMed ID: 14672357
[TBL] [Abstract][Full Text] [Related]
18. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
19. Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
Strauss LG; Klippel S; Pan L; Schönleben K; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):868-77. PubMed ID: 17219134
[TBL] [Abstract][Full Text] [Related]
20. Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.
Dimitrakopoulou-Strauss A; Hoffmann M; Bergner R; Uppenkamp M; Haberkorn U; Strauss LG
Clin Nucl Med; 2009 Sep; 34(9):576-84. PubMed ID: 19692817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]